Nanobiotix SA of France has appointed two industry veterans to its supervisory board to help oversee its business in nanomedicines. The first, Anne-Marie Graffin, is a consultant and former executive at Sanofi Pasteur where she managed the marketing of adult vaccines in Europe. She has been joined on the board by Enno Spillner who is currently the chief executive officer and the chief financial officer of the German drug discovery company, 4SC AG. Prior to joining 4SC, Mr Spillner was a managing partner of the venture capital fund, BioM AG.
Nanobiotix announced the appointments on 16 January 2014.
Copyright 2014 Evernow Publishing Ltd